SANOFI
Beginning in July 2024, Anthony Aouad will assume general management of Sanofi Hellas as well as the pharmaceutical business unit for Greece, Hungary, and Ukraine.
04/07/24 • 11:46
Commercialization of the product by Lavipharm is expected to take place upon completion of the relevant marketing authorization transfer, during Q2 of 2024
11/12/23 • 12:47